Albemarle Tidigare resultatutveckling
Tidigare kriterier kontrolleras 0/6
Albemarle s intäkter har minskat med en genomsnittlig årlig takt på -33.8%, medan Chemicals -branschen såg intäkter på sjunkande 4% årligen. Intäkterna har varit växande med en genomsnittlig takt på 7.1% per år.
Viktig information
-33.80%
Tillväxttakt i vinsten
-33.98%
Tillväxttakt för EPS
| Chemicals Tillväxt i branschen | 12.93% |
| Intäkternas tillväxttakt | 7.13% |
| Avkastning på eget kapital | -1.84% |
| Nettomarginal | -7.27% |
| Senaste uppdateringen av resultatet | 31 Mar 2026 |
Senaste uppdateringar av tidigare prestationer
Recent updates
Seeking Alpha • Jun 24
Albemarle: Why $20 Lithium Changes Everything
Summary Albemarle Corporation is rated Buy with a 12-month price target of $205, reflecting strong earnings leverage to recovering lithium prices. Q1 results demonstrate robust financial improvement: net sales up 33% YoY, adjusted EBITDA up 148%, and FCF at $248 million, driven by higher lithium prices and volumes. Grid-scale energy storage is emerging as a major lithium demand driver, with battery order books full through 2027 and demand growth trending above guidance. ALB's healthy balance sheet—$2.7B liquidity, 1x net debt/EBITDA, no major maturities until 2028—supports profitable growth and cushions against commodity price volatility. Read the full article on Seeking AlphaAnalysartikel • Jun 21
Albemarle (ALB) Stock Could Be 24.6% Undervalued After Recent Share Price Weakness
Albemarle (ALB) has drawn fresh attention after recent share price weakness, with the stock down 6% over the past month and 4% over the past 3 months. This has prompted investors to reassess its valuation and business mix. See our latest analysis for Albemarle. Beyond the recent weakness, Albemarle’s 1 day share price return of down 3.73% and 7 day return of down 5.91% sit against a year to date share price gain of 11.41%. The 1 year total shareholder return of about 1.9x contrasts with...
Uppdatering av berättelse • Jun 13
ALB: Elevated Lithium Optimism Will Likely Pressure Future Share Returns
Albemarle's updated analyst price target rises by about $5 to $131, as analysts highlight higher long term volume potential, tighter lithium operating rates and a shift to a richer 17.8x future P/E multiple, despite more conservative assumptions for revenue growth and profit margins. Analyst Commentary Recent Street research on Albemarle reflects a mix of optimism around long term lithium volume potential and more guarded views on how much of this is already reflected in the stock price.
Uppdatering av berättelse • May 30
ALB: Future Returns Will Rely On Tightening Lithium Supply And Cost Discipline
The analyst fair value estimate for Albemarle has increased from $172.62 to $212.74. Analysts attribute the updated view to higher target prices, expectations for mid single digit volume growth from key lithium assets, and ongoing cost discipline.
Uppdatering av berättelse • May 13
ALB: Lithium Recovery And Cost Discipline Will Drive Future Re Rating
Albemarle's analyst price target has shifted from $245 to $264, with analysts pointing to recent broad based target raises and updated assumptions on lithium pricing, capital discipline, and a higher future P/E multiple as key drivers behind the change. Analyst Commentary Recent research points to a clear shift in tone around Albemarle, with a series of price target raises and selected upgrades framed around improving lithium fundamentals, tighter cost control, and a willingness to reward shareholders for disciplined capital allocation.Uppdatering av berättelse • Apr 29
ALB: Lithium Price Recovery And Cost Discipline Will Drive Bullish Re Rating
Analysts have nudged Albemarle's implied fair value estimate higher, with the target moving from $230 to $245 as they factor in slightly stronger revenue growth expectations, a modestly higher profit margin outlook, and updated P/E assumptions following a series of recent target hikes and mixed rating changes across the Street. Analyst Commentary Recent research on Albemarle shows a cluster of higher price targets and selective upgrades, even as a few firms trim targets or ratings.Uppdatering av berättelse • Apr 15
ALB: Lithium Price Recovery And Cost Discipline Will Support Bullish Re Rating
Analysts have raised their average price targets for Albemarle by double-digit dollar amounts, placing them in the $150 to $230 range. They cite higher lithium price assumptions, more constructive views on supply and demand, and ongoing cost discipline as key supports for the updated valuation inputs.Uppdatering av berättelse • Apr 01
ALB: Lithium Tightening And Cost Discipline Will Drive Bullish Re Rating Ahead
Analysts have nudged Albemarle's price targets higher across the board, with several firms lifting their views by $10 to more than $100, as they point to stronger lithium pricing, disciplined cost control, and improving sentiment around electric vehicle and energy storage demand. Analyst Commentary Bullish analysts are leaning into a more constructive view on Albemarle, with a cluster of upgrades and higher price targets tied to lithium pricing, cost discipline, and renewed interest in battery supply chains.Uppdatering av berättelse • Mar 18
ALB: Lithium Price Rally Will Likely Curb Future Share Returns
The analyst price target for Albemarle has been revised higher to $126.39 from $75.00. Analysts point to stronger lithium pricing, tighter inventories, and ongoing cost and capital expenditure discipline as key reasons for the shift.Uppdatering av berättelse • Mar 03
ALB: Lithium Tightening And Price Recovery Will Support Re Rating Ahead
Albemarle's updated analyst price targets have moved higher, with several firms lifting their ranges into roughly the mid to low $200s as analysts point to stronger lithium pricing, tighter inventories, and what they view as improving supply and demand fundamentals for the commodity. Analyst Commentary Recent Street research on Albemarle shows a clear tilt toward more constructive views, with many bullish analysts increasing price targets across a wide range and several moving to more positive ratings.Uppdatering av berättelse • Feb 17
ALB: Lithium Supply Tightening And Pricing Recovery Will Drive Re Rating
The analyst price target for Albemarle has been raised to $230, up from $143.88, as analysts factor in stronger lithium pricing, improved supply and demand expectations, and updated views on margins and future price-to-earnings (P/E) multiples. Analyst Commentary Recent Street research on Albemarle has tilted more positive, with several bullish analysts lifting price targets and moving to more constructive ratings.Analysartikel • Feb 12
Newsflash: Albemarle Corporation (NYSE:ALB) Analysts Have Been Trimming Their Revenue Forecasts
The analysts covering Albemarle Corporation ( NYSE:ALB ) delivered a dose of negativity to shareholders today, by...Uppdatering av berättelse • Feb 03
ALB: Future Returns Will Depend On Sustained Lithium Tightness And Pricing Power
The analyst price target for Albemarle has been raised from about $148 to roughly $173. This change reflects analysts' use of a slightly lower discount rate, modestly higher revenue growth assumptions, and a higher future P/E multiple, supported by a series of recent target hikes and upgrades tied to stronger lithium pricing and tightening supply expectations.Uppdatering av berättelse • Jan 20
ALB: Future Returns Will Hinge On Sustained Lithium Pricing Strength
The analyst price target for Albemarle has been raised from about $125.49 to roughly $147.79 as analysts factor in higher lithium price assumptions, improved profit margin expectations, and a lower future P/E multiple, supported by a broad wave of recent upgrades and target increases across major research firms. Analyst Commentary Recent research on Albemarle reflects a clear shift toward more constructive views, with several upgrades and higher targets built around revised lithium price decks, inventory tightness, and evolving demand themes such as energy storage and physical AI.Analysartikel • Jan 07
Albemarle Corporation (NYSE:ALB) Stocks Shoot Up 26% But Its P/S Still Looks Reasonable
Albemarle Corporation ( NYSE:ALB ) shares have continued their recent momentum with a 26% gain in the last month alone...Uppdatering av berättelse • Jan 05
ALB: Future Returns Will Depend On Lithium Pricing Outpacing Current Optimism
Narrative Update The analyst price target for Albemarle has increased from about $107 to roughly $125 as analysts incorporate updated lithium pricing assumptions, expectations for stronger medium-term earnings power, and slightly improved margin outlooks. These changes are reflected in a higher assumed future P/E multiple.Uppdatering av berättelse • Dec 18
ALB: Lithium Price Rebound Is Expected To Limit Future Share Upside
Analysts have raised our Albemarle fair value estimate to $75 from $58, reflecting higher projected lithium prices, improved demand expectations, and stronger medium term earnings power. Analyst Commentary Recent Street research on Albemarle has turned incrementally constructive on lithium pricing and near term earnings, but the overall tone remains balanced as many price targets and ratings embed limited upside from current levels.Uppdatering av berättelse • Dec 04
ALB: Future Returns Will Hinge On Sustained Lithium Price Recovery
Analysts have nudged our Albemarle fair value estimate higher to approximately $107 from about $103 per share, reflecting modestly improved lithium price expectations and slightly stronger long term earnings power despite still limited perceived upside. Analyst Commentary Street research has broadly shifted in a more constructive direction on Albemarle, with a series of target price increases reflecting higher assumed lithium prices and improved earnings power.Analysartikel • Nov 25
Albemarle (NYSE:ALB) Has Announced A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend on the 2nd of January, with...Uppdatering av berättelse • Nov 20
ALB: Future Stock Performance Will Depend On Sustained Lithium Price Recovery
Albemarle's analyst price target has increased significantly, reflecting a new consensus valuation of approximately $103 per share. Analysts cite improved lithium demand expectations, earlier achievement of higher average sales prices, and enhanced market fundamentals as key drivers behind the upward revision.Analysartikel • Nov 18
Albemarle Corporation's (NYSE:ALB) 27% Share Price Surge Not Quite Adding Up
Albemarle Corporation ( NYSE:ALB ) shares have continued their recent momentum with a 27% gain in the last month alone...Uppdatering av berättelse • Nov 05
ALB: Future Earnings Outlook Will Balance Rising Lithium Prices And Chile Supply Uncertainties
The analyst price target for Albemarle has been revised upward from $92.92 to $96.45. Analysts point to favorable lithium price trends and improved earnings prospects as key drivers for the adjustment.Analysartikel • Oct 31
Albemarle (NYSE:ALB) Is Due To Pay A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend on the 2nd of January, with...Uppdatering av berättelse • Oct 22
Analysts Adjust Targets for Albemarle Amid Lithium Market Shifts and Safety Incident in Chile
Albemarle's analyst price target has increased to $100 from $95, as analysts cite recent government investments and evolving lithium supply dynamics as factors supporting a higher fair value for the stock. Analyst Commentary Recent analyst reports on Albemarle reflect a mix of optimism and caution, as shifting lithium supply dynamics and significant government involvement continue to shape the company's outlook and valuation.Uppdatering av berättelse • Oct 08
Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential
Albemarle's analyst price target has increased from approximately $86.65 to $87.79, as analysts cite improving lithium market conditions, particularly due to actions related to supply in China, and slightly stronger profit margins supporting the updated valuation. Analyst Commentary Recent analyst activity on Albemarle reflects a shift in sentiment in response to market dynamics and company-specific developments.Uppdatering av berättelse • Sep 23
Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential
Analysts have slightly raised Albemarle’s price target from $85.47 to $86.65, citing increased uncertainty around global lithium supply due to China mine closures, which reduces downside risk and may support a sustained lithium price recovery. Analyst Commentary China mine site closures have increased uncertainty around global lithium supply, raising the potential for sustained improvement in lithium prices.Analysartikel • Sep 09
Albemarle (NYSE:ALB) Will Pay A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend on the 1st of October, with...Analysartikel • Sep 01
Albemarle Corporation's (NYSE:ALB) Shares Climb 25% But Its Business Is Yet to Catch Up
Albemarle Corporation ( NYSE:ALB ) shares have continued their recent momentum with a 25% gain in the last month alone...Uppdatering av berättelse • Aug 28
Policy Tailwinds And Cost Cuts Will Unlock Lithium Potential
Upward revisions to Albemarle's price target reflect improved sentiment as China lithium mine closures introduce upside risk to lithium prices and temper bearish views, resulting in a consensus analyst price target increase from $83.79 to $85.01. Analyst Commentary Recent China lithium mine site closures have introduced upside risk to lithium prices, challenging the prolonged bearish outlook for Albemarle.Analysartikel • Aug 15
Albemarle (NYSE:ALB) Is Due To Pay A Dividend Of $0.405
Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend of $0.405 per share on the 1st of October...Analysartikel • Jul 31
Albemarle (NYSE:ALB) Is Paying Out A Dividend Of $0.405
The board of Albemarle Corporation ( NYSE:ALB ) has announced that it will pay a dividend of $0.405 per share on the...Analysartikel • Jul 18
Albemarle Corporation's (NYSE:ALB) 27% Share Price Surge Not Quite Adding Up
Despite an already strong run, Albemarle Corporation ( NYSE:ALB ) shares have been powering on, with a gain of 27% in...Analysartikel • Jul 02
Is Albemarle (NYSE:ALB) Using Too Much Debt?
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Ny berättelse • Apr 22
Optimized Conversion Network And Capex Cuts Will Secure Lithium Stability
Optimization and cost efficiency efforts could improve Albemarle's margins despite volatile lithium prices, enhancing earnings stability.Seeking Alpha • Apr 10
Albemarle: Tariff War Triggers Richer Yields And Improved Upside Potential
Summary ALB has fallen drastically since 2022 peaks, thanks to the moderating lithium spot prices, the over-supply issues in 2025, and the intensified tariff/trade war. This is on top of the potential impacts on near-term energy storage/EV demand, since lithium may be twice tariffed attributed to the global mining/ packaging/ final product development. Even so, ALB appears to be well capitalized to weather the near-term headwinds, thanks to the healthier balance sheet and Talison Joint Venture being adj EBITDA accretive from 2026/2027 onwards. This is on top of the projected lithium deficit from 2026 onwards, with it likely to trigger higher spot prices and improved top/bottom lines then. With ALB now offering a relatively rich total operational return at double digits, we are upgrading to a cautious Buy with numerous caveats. Read the full article on Seeking AlphaFördelning av intäkter och kostnader
Fördelning av intäkter och kostnader
Hur Albemarle tjänar och spenderar pengar. Baserat på senast rapporterade resultat, på rullande tolvmånadersbasis.
Resultat- och intäktshistorik
| Datum | Intäkter | Intäkter | G+A Kostnader | FoU-kostnader |
|---|---|---|---|---|
| 31 Mar 26 | 5,495 | -400 | 559 | 46 |
| 31 Dec 25 | 5,143 | -677 | 543 | 51 |
| 30 Sep 25 | 4,946 | -188 | 503 | 59 |
| 30 Jun 25 | 4,993 | -1,096 | 523 | 69 |
| 31 Mar 25 | 5,094 | -1,307 | 558 | 77 |
| 31 Dec 24 | 5,378 | -1,316 | 595 | 87 |
| 30 Sep 24 | 6,502 | -1,967 | 647 | 89 |
| 30 Jun 24 | 7,458 | -554 | 655 | 88 |
| 31 Mar 24 | 8,398 | 326 | 654 | 89 |
| 31 Dec 23 | 9,617 | 1,573 | 869 | 86 |
| 30 Sep 23 | 9,882 | 3,324 | 570 | 83 |
| 30 Jun 23 | 9,663 | 3,918 | 532 | 80 |
| 31 Mar 23 | 8,773 | 3,675 | 483 | 76 |
| 31 Dec 22 | 7,320 | 2,690 | 439 | 72 |
| 30 Sep 22 | 5,593 | 1,554 | 393 | 64 |
| 30 Jun 22 | 4,332 | 264 | 365 | 59 |
| 31 Mar 22 | 3,626 | 281 | 363 | 55 |
| 31 Dec 21 | 3,328 | 124 | 333 | 54 |
| 30 Sep 21 | 3,313 | 212 | 450 | 57 |
| 30 Jun 21 | 3,229 | 703 | 439 | 58 |
| 31 Mar 21 | 3,219 | 364 | 418 | 58 |
| 31 Dec 20 | 3,129 | 376 | 427 | 59 |
| 30 Sep 20 | 3,242 | 382 | 411 | 58 |
| 30 Jun 20 | 3,375 | 438 | 430 | 60 |
| 31 Mar 20 | 3,496 | 507 | 453 | 59 |
| 31 Dec 19 | 3,589 | 533 | 470 | 58 |
| 30 Sep 19 | 3,519 | 572 | 440 | 60 |
| 30 Jun 19 | 3,417 | 547 | 432 | 61 |
| 31 Mar 19 | 3,385 | 695 | 417 | 64 |
| 31 Dec 18 | 3,375 | 694 | 415 | 70 |
| 30 Sep 18 | 3,311 | 346 | 410 | 75 |
| 30 Jun 18 | 3,288 | 335 | 416 | 80 |
| 31 Mar 18 | 3,172 | 135 | 421 | 81 |
| 31 Dec 17 | 3,072 | 55 | 420 | 79 |
| 30 Sep 17 | 2,911 | 315 | 431 | 77 |
| 30 Jun 17 | 2,810 | 302 | 416 | 75 |
| 31 Mar 17 | 2,742 | 282 | 396 | 78 |
| 31 Dec 16 | 2,677 | 442 | 355 | 79 |
| 30 Sep 16 | 2,703 | 560 | 303 | 82 |
| 30 Jun 16 | 2,742 | 510 | 297 | 84 |
| 31 Mar 16 | 2,791 | 468 | 299 | 86 |
| 31 Dec 15 | 2,826 | 302 | 300 | 89 |
| 30 Sep 15 | 2,702 | 124 | 397 | 89 |
| 30 Jun 15 | 2,652 | 149 | 382 | 89 |
Kvalitetsintäkter: ALB är för närvarande olönsam.
Växande vinstmarginal: ALB är för närvarande olönsam.
Fritt kassaflöde vs resultatanalys
Analys av tidigare vinsttillväxt
Resultatutveckling: ALB är olönsam och förlusterna har ökat under de senaste 5 åren i en takt av 33.8% per år.
Accelererande tillväxt: Det går inte att jämföra ALB s intäktstillväxt under det senaste året med dess 5-åriga genomsnitt eftersom det för närvarande är olönsamt
Resultat vs industri: ALB är olönsam, vilket gör det svårt att jämföra det senaste årets vinsttillväxt med Chemicals branschen ( 0.1% ).
Avkastning på eget kapital
Hög ROE: ALB har en negativ avkastning på eget kapital ( -1.84% ), eftersom det för närvarande är olönsamt.
Avkastning på tillgångar
Avkastning på sysselsatt kapital
Upptäck starka bolag som tidigare presterat bra
Företagsanalys och finansiella data Status
| Uppgifter | Senast uppdaterad (UTC-tid) |
|---|---|
| Analys av företag | 2026/06/24 15:50 |
| Aktiekurs vid dagens slut | 2026/06/24 00:00 |
| Intäkter | 2026/03/31 |
| Årlig intjäning | 2025/12/31 |
Datakällor
Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.
| Paket | Uppgifter | Tidsram | Exempel US-källa |
|---|---|---|---|
| Företagets finansiella ställning | 10 år |
| |
| Analytikernas konsensusuppskattningar | +3 år |
|
|
| Marknadspriser | 30 år |
| |
| Ägarskap | 10 år |
| |
| Förvaltning | 10 år |
| |
| Viktiga utvecklingstendenser | 10 år |
|
* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.
Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.
Analysmodell och snöflinga
Detaljer om analysmodellen som används för att skapa denna rapport finns på vår Github-sida; vi har också guider om hur du använder våra rapporter och handledningar på Youtube.
Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.
Industri- och sektormått
Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.
Källor för analytiker
Albemarle Corporation bevakas av 36 analytiker. 19 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.
| Analytiker | Institution |
|---|---|
| William Selesky | Argus Research Company |
| Benjamin Kallo | Baird |
| Andres Castanos-Mollor | Berenberg |